MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Piroxicam

CAS No. : 36322-90-4

MCE 站：Piroxicam

产品活性：Piroxicam (CP-16171) 是一种非甾体抗炎剂，能够抑制 COX 的活性，对人单核细胞 COX-1 和 COX-2 的 IC₅₀ 值分别为 47 和 25 μM。

研究领域：Immunology/Inflammation

作用靶点：COX

In Vitro: Piroxicam (CP-16171) is a non-steroidal anti-inflammatory drugs, acts as a COX inhibitor, with IC₅₀s of 47, 25 μM for human monocyte COX-1 and COX-2, respectively. Piroxicam (CP-16171) (167, 333, 500 μM) decreases cell population of T24 and the 5637 cells. Piroxicam (CP-16171) (500 μM) also reduces the cell viability of T24 and 5637 cell, and is significantly effective when combined with 0.05 μM carboplatin. The combination also inhibits Ki-67 expression in booth cells.

In Vivo: Piroxicam (CP-16171) (0.3 mg/kg qd 24-h p.o.) reduces tumor volume in 12 of 18 dogs, and such and effect is via induction of apoptosis and reduction in urine basic fibroblast growth factor concentration.

相关产品：Drug Repurposing Compound Library Plus  |  FDA-Approved Drug Library Plus  |  FDA-Approved Drug Library Mini  |  Bioactive Compound Library Plus  |  Immunology/Inflammation Compound Library  |  FDA-Approved Drug Library  |  Anti-Cancer Compound Library  |  CNS-Penetrant Compound Library  |  Anti-Aging Compound Library  |  Drug Repurposing Compound Library  |  Anti-COVID-19 Compound Library  |  NMPA-Approved Drug Library  |  Pyroptosis Compound Library  |  Orally Active Compound Library  |  FDA Approved & Pharmacopeial Drug Library  |  Drug-Induced Liver Injury (DILI) Compound Library  |  Anti-Pancreatic Cancer Compound Library  |  Acetaminophen  |  Indomethacin  |  Celecoxib  |  Aspirin  |  Ibuprofen  |  Catechin  |  NS-398  |  Diclofenac  |  20(S)-Ginsenoside Rg3  |  Naproxen  |  (-)-Epicatechin  |  Gallic acid  |  Xanthohumol  |  Sulindac  |  SC-560  |  Carprofen  |  Salicylic acid  |  Meloxicam  |  Rutaecarpine  |  Rebamipide  |  Iguratimod  |  Flufenamic acid  |  Fenofibric acid  |  Isoorientin  |  Nabumetone  |  Neochlorogenic acid  |  Rofecoxib  |  Ginsenoside C-K

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。